Spots Global Cancer Trial Database for neoplasm metastasis
Every month we try and update this database with for neoplasm metastasis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone | NCT00545129 | Neoplasm Metast... Palliative Care | Tanezumab 10 mg... IV Placebo for ... | 18 Years - | Pfizer | |
| Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors | NCT03510104 | Advanced Cancer Metastatic Canc... Neoplasms Neoplasm Metast... Neoplastic Proc... Pathologic Proc... | MRX-2843 | 18 Years - | Meryx, Inc. | |
| Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | NCT01846429 | Tumor Cancer Pain Malignant Solid... Unresectable Ma... Hematologic Mal... Multiple Myelom... Lymphoma Neoplasm Metast... | Sodium Bicarbon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of LY3022855 In Participants With Breast or Prostate Cancer | NCT02265536 | Neoplasms Neoplasm Metast... | LY3022855 | 18 Years - | Eli Lilly and Company | |
| Stereotactic Body Radiotherapy Followed by Surgical Stabilization in Spinal Metastases | NCT05060653 | Spinal Neoplasm... Neoplasm Metast... Radiosurgery Surgery | SBRT followed b... | 18 Years - | UMC Utrecht | |
| A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies | NCT00781612 | Neoplasm Metast... | Docetaxel Paclitaxel Pertuzumab Trastuzumab Trastuzumab Emt... Atezolizumab | 18 Years - | Genentech, Inc. | |
| Study of Noni in Cancer Patients | NCT00033878 | Neoplasms Neoplasm Metast... | Noni Extract | - | National Center for Complementary and Integrative Health (NCCIH) | |
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) | NCT01231022 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | ||
| Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer | NCT00281528 | Breast Neoplasm... Neoplasm Metast... | ABI-007 (Abraxa... bevacizumab | 18 Years - | Celgene | |
| A Study to Test Lung Function After Radiation Therapy | NCT01039649 | Lung Neoplasms Neoplasm Metast... | 18 Years - | University of Iowa | ||
| Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation | NCT00178243 | Liver Neoplasms Neoplasm Metast... | 3D Conformal Ra... | 18 Years - | University of Rochester | |
| Hepatic Artery Infusion Pump for NPC Liver Metastases | NCT03876574 | Nasopharyngeal ... Neoplasm Metast... Liver | DSA-guided impl... Gemcitabine Floxuridine dexamethasone | - | Xiangya Hospital of Central South University | |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | NCT05322486 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Neoplasms, Seco... Neoplasm Metast... Digestive Syste... Gastrointestina... Colonic Disease Intestinal Dise... Rectal Diseases | surgery of the ... chemotherapy | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
| A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test | NCT01649453 | Neoplasm Metast... | Pathwork® Tissu... | 18 Years - | Cedar Associates LLC | |
| A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body | NCT02014116 | Neoplasms Neoplasm Metast... Melanoma Carcinoma, Non-... Colorectal Neop... | LY3009120 capsu... | 18 Years - | Eli Lilly and Company | |
| A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely | NCT03175146 | Colonic Neoplas... Neoplasm Metast... | Stereotactic Bo... | 18 Years - 80 Years | AHS Cancer Control Alberta | |
| SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases | NCT03694015 | Neoplasm Metast... Neoplastic Proc... Neoplasms Pathologic Proc... | SUPR VMAT | 18 Years - | British Columbia Cancer Agency | |
| A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread | NCT03166631 | Neoplasms Neoplasm Metast... Carcinoma, Non-... | BI 891065 BI 754091 | 18 Years - | Boehringer Ingelheim | |
| Biomarker Development for Response Prediction by DNA Mutational Analysis | NCT01855061 | Neoplasm Metast... | Biopsy Blood samples Pharmacokinetic... Midazolam clear... | 18 Years - | UMC Utrecht | |
| Metastatic Gastric Cancer FFCD 03-07 | NCT00374036 | Stomach Cancer Neoplasm Metast... | ECC FOLFIRI | 18 Years - | University Hospital, Toulouse | |
| Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) | NCT04281784 | Dementia Chronic Disease Neoplasm Metast... Lung Neoplasm Pulmonary Disea... Heart Failure，C... Liver Cirrhosis Kidney Failure,... Lung Diseases, ... Peripheral Vasc... Diabetes With E... Palliative Care... Health Care Qua... Patient Care Inpatients Health Communic... Patient Care Pl... | EHR-based Clini... | 18 Years - | University of Washington | |
| Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer | NCT02495532 | Colorectal Neop... Neoplasm Metast... | Lymph node clea... Lymph node clea... | 18 Years - | Hospital Moinhos de Vento | |
| Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum | NCT00346099 | Rectal Cancer Neoplasm Metast... | Panitumumab wit... Panitumumab wit... | 18 Years - | NSABP Foundation Inc | |
| Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00323882 | Prostate Cancer Neoplasm Metast... | MDX-010 | 18 Years - | Bristol-Myers Squibb | |
| Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer | NCT00317720 | Breast Cancer Neoplasm Metast... | Trastuzumab RAD001 | 18 Years - | M.D. Anderson Cancer Center | |
| Phase 2 Trial of Bevacizumab in Combination With Pemetrexed | NCT00227019 | Non-small Cell ... Lung Cancer Neoplasm Metast... | Bevacizumab Pemetrexed Vitamin B12 Folate Dexamethasone | 18 Years - | Stanford University | |
| Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases | NCT01461252 | Pain Neoplasm Metast... | Cryoablation Radiation | 18 Years - | Boston Scientific Corporation | |
| Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer | NCT00120172 | Colorectal Canc... Neoplasm Metast... | oxaliplatin, ca... | 65 Years - | Geriatric Oncology Consortium | |
| Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. | NCT00270491 | Breast Cancer Neoplasm Metast... | Paclitaxel Capecitabine | 18 Years - | ARCAGY/ GINECO GROUP | |
| Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer | NCT01186601 | Neoplasms | PET tracer (BAY... | 18 Years - 90 Years | Life Molecular Imaging SA | |
| A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC) | NCT02411591 | Carcinoma, Non-... Neoplasm Metast... | Necitumumab Abemaciclib | 18 Years - | Eli Lilly and Company | |
| Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases | NCT00119899 | Colorectal Live... Colorectal Canc... Neoplasm Metast... | FDG-PET scan | 18 Years - 75 Years | Radboud University Medical Center | |
| S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen | NCT00602745 | Pancreatic Neop... Neoplasm Metast... | S-1 5-Fluorouracil | 18 Years - | Sanofi | |
| A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) | NCT04886804 | Neoplasm Metast... Non-Small Cell ... | zongertinib | 18 Years - | Boehringer Ingelheim | |
| A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone | NCT00545129 | Neoplasm Metast... Palliative Care | Tanezumab 10 mg... IV Placebo for ... | 18 Years - | Pfizer | |
| A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) | NCT04886804 | Neoplasm Metast... Non-Small Cell ... | zongertinib | 18 Years - | Boehringer Ingelheim | |
| Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC) | NCT00125034 | Neoplasm Metast... Colorectal Canc... | Cetuximab Oxaliplatin | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| A Study of LY2835219 in Participants With Cancer | NCT02117648 | Neoplasm Neoplasm Metast... | Abemaciclib Clarithromycin | 18 Years - | Eli Lilly and Company | |
| Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours | NCT03697304 | Neoplasm Metast... | BI 754091 BI 754111 BI 836880 | 18 Years - | Boehringer Ingelheim | |
| Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer | NCT02228356 | Neoplasm Metast... | Stereotactic Bo... | 18 Years - 100 Years | Universitair Ziekenhuis Brussel | |
| Study of NS-9 in Patients With Liver Metastases | NCT00094003 | Liver Neoplasms Neoplasm Metast... Local Neoplasm ... | NS-9 [Poly I: P... | 18 Years - | NS Pharma, Inc. | |
| Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer | NCT00165568 | Colorectal Canc... Neoplasm Metast... | Bevacizumab | 18 Years - | Dana-Farber Cancer Institute | |
| Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours | NCT00710268 | Neoplasm Metast... | AZD2281 Bevacizumab | 18 Years - | AstraZeneca | |
| Docetaxel and Capecitabine in Advanced Gastric Cancer | NCT00142038 | Stomach Neoplas... Neoplasm Metast... | Docetaxel Capecitabine | 18 Years - 75 Years | Charite University, Berlin, Germany | |
| Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) | NCT04281784 | Dementia Chronic Disease Neoplasm Metast... Lung Neoplasm Pulmonary Disea... Heart Failure，C... Liver Cirrhosis Kidney Failure,... Lung Diseases, ... Peripheral Vasc... Diabetes With E... Palliative Care... Health Care Qua... Patient Care Inpatients Health Communic... Patient Care Pl... | EHR-based Clini... | 18 Years - | University of Washington | |
| Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours | NCT00633269 | Neoplasm Metast... | AZD2281 | 18 Years - | AstraZeneca | |
| A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases | NCT00124761 | Neoplasm Metast... Brain Neoplasm | Surgery + WBRT Radiosurgery + ... | 18 Years - | Royal Adelaide Hospital | |
| ECI301 and Radiation for Advanced or Metastatic Cancer | NCT01441115 | Cancer Neoplasm Metast... Radiation Oncol... Neoplasm Metastasis | Radiation Thera... ECI301 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Study of LY2157299 in Japanese Participants With Cancer | NCT01722825 | Neoplasms Neoplasm Metast... | LY2157299 | 20 Years - | Eli Lilly and Company | |
| 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC) | NCT00433927 | Neoplasm Metast... Colorectal Canc... | 5-FU folinic acid irinotecan cetuximab bevacizumab | 18 Years - 75 Years | Ludwig-Maximilians - University of Munich | |
| LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection | NCT05138094 | Colorectal Neop... Neoplasm Metast... | Minimally invas... Minimally invas... | 18 Years - | Fondazione Poliambulanza Istituto Ospedaliero | |
| Tumor RNA Transfected Dendritic Cell Vaccines | NCT00108264 | Prostate Cancer | Tumor RNA trans... | 10 Years - | VA Office of Research and Development | |
| A Study of LY3022855 In Participants With Breast or Prostate Cancer | NCT02265536 | Neoplasms Neoplasm Metast... | LY3022855 | 18 Years - | Eli Lilly and Company | |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan | NCT05573893 | Breast Neoplasm... Breast Cancer Neoplasm Metast... | 18 Years - 130 Years | AstraZeneca | ||
| A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. | NCT00478270 | Pain Bone Neoplasm Neoplasm Metast... | ibandronate [Bo... | 18 Years - | Hoffmann-La Roche | |
| Molecular Markers in Treatment in Endometrial Cancer | NCT00598845 | Endometrial Neo... Neoplasm Metast... | Tumor biopsy st... | - | University of Bergen | |
| Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer | NCT01972503 | Colorectal Neop... Neoplasm Metast... Liver Neoplasms | 5-FU and oxalip... colorectal canc... | 18 Years - 75 Years | Fudan University | |
| Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. | NCT06046131 | Prostatic Neopl... Adenocarcinoma Neoplasm Recurr... Neoplasm Metast... | Standard care | 18 Years - | Centre Hospitalier Universitaire de Pointe-a-Pitre | |
| Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer | NCT00643877 | Colorectal Neop... | Preoperative he... surgery | 18 Years - 74 Years | Fudan University | |
| A Study Of PF-06664178 In Patients With Advanced Solid Tumors | NCT02122146 | Neoplasms | PF-06664178 PF-06664178 | 18 Years - | Pfizer | |
| Personalised Disease Monitoring in Metastatic Breast Cancer | NCT04597580 | Breast Cancer M... Estrogen Recept... | 18 Years - | The Christie NHS Foundation Trust | ||
| For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy | NCT00037180 | Neoplasm Metast... Colorectal Neop... | Celecoxib Irinotecan 5-fluorouracil Leucovorin | 18 Years - | Pfizer | |
| Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases | NCT01489787 | Neoplasm Metast... | HIFU HIFU HIFU | 18 Years - | Centre Leon Berard | |
| Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer | NCT05169567 | Breast Neoplasm Neoplasm Metast... | Abemaciclib Fulvestrant Placebo | 18 Years - | Eli Lilly and Company | |
| Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer | NCT00116506 | Colorectal Canc... Neoplasm Metast... | erlotinib FOLFOX bevacizumab | 18 Years - | Dana-Farber Cancer Institute | |
| Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer | NCT00519285 | Prostatic Neopl... Neoplasm Metast... | Aflibercept Placebo (for af... Docetaxel Prednisone or P... | 18 Years - | Sanofi | |
| Docetaxel and Capecitabine in Advanced Gastric Cancer | NCT00142038 | Stomach Neoplas... Neoplasm Metast... | Docetaxel Capecitabine | 18 Years - 75 Years | Charite University, Berlin, Germany | |
| Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen | NCT00561470 | Colorectal Neop... Neoplasm Metast... | Placebo Aflibercept (zi... FOLFIRI (Irinot... FOLFIRI (Irinot... | 18 Years - | Sanofi | |
| Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer | NCT00444678 | Colorectal Canc... Neoplasm Metast... | Cetuximab Oxaliplatin Capecitabine | 18 Years - | NYU Langone Health | |
| A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks | NCT00728390 | Carcinoma, Non-... Neoplasm Metast... | PF-00299804 | 18 Years - | Pfizer | |
| A Study of LY3537982 Plus Immunotherapy With or Without Chemotherapy in Participants With Non-Small Cell Lung Cancer (NSCLC) With a Change in a Gene Called KRAS G12C | NCT06119581 | Carcinoma, Non-... Neoplasm Metast... | LY3537982 Pembrolizumab Placebo Cisplatin Carboplatin Pemetrexed | 18 Years - | Eli Lilly and Company | |
| Proteome-based Immunotherapy of Brain Metastases From Breast Cancer | NCT01782274 | Neoplasm Metast... | Dendritic vacci... Dendritic vacci... | 18 Years - 70 Years | NeuroVita Clinic | |
| Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases | NCT00434317 | Neoplasm Metast... | Zoledronic acid | 18 Years - | Novartis | |
| Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients | NCT02583828 | Breast Neoplasm... Neoplasm Metast... | Cyclophosphamid... Letrozole 2.5 m... | 65 Years - | Capital Medical University | |
| Pilot Study to Test the Feasibility and the Efficacy of the German Language Adapted PRO-SELF© Plus Pain Control Program | NCT00920504 | Neoplasm Metast... | German PRO-SELF... Standard Care | 18 Years - | University Hospital, Basel, Switzerland | |
| Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer | NCT00120172 | Colorectal Canc... Neoplasm Metast... | oxaliplatin, ca... | 65 Years - | Geriatric Oncology Consortium | |
| Docetaxel and Capecitabine in Advanced Gastric Cancer | NCT00142038 | Stomach Neoplas... Neoplasm Metast... | Docetaxel Capecitabine | 18 Years - 75 Years | Charite University, Berlin, Germany | |
| Robotic Compared to Fixed Gantry Radiosurgery for Brain Metastases | NCT01353573 | Metastatic Mali... | Fixed Gantry Ra... Robotic Radiosu... | 18 Years - | Hamilton Health Sciences Corporation | |
| CCR5-blockade in Metastatic Colorectal Cancer | NCT01736813 | Colorectal Canc... Neoplasm Metast... Liver Metastase... | Maraviroc | 18 Years - | National Center for Tumor Diseases, Heidelberg | |
| Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours | NCT03697304 | Neoplasm Metast... | BI 754091 BI 754111 BI 836880 | 18 Years - | Boehringer Ingelheim |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
